Ludeman J P, Whisstock J C, Hopkins P C, Le Bonniec B F, Bottomley S P
Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria 3800, Australia.
Biophys J. 2001 Jan;80(1):491-7. doi: 10.1016/S0006-3495(01)76031-6.
The x-ray crystal structure of the serpin-proteinase complex is yet to be determined. In this study we have investigated the conformational changes that take place within antitrypsin during complex formation with catalytically inactive (thrombin(S195A)) and active thrombin. Three variants of antitrypsin Pittsburgh (an effective thrombin inhibitor), each containing a unique cysteine residue (Cys(232), Cys(P3'), and Cys(313)) were covalently modified with the fluorescence probe N,N'-dimethyl-N-(iodoacetyl)-N'-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)ethylenediamine. The presence of the fluorescent label did not affect the structure or inhibitory activity of the serpin. We monitored the changes in the fluorescence emission spectra of each labeled serpin in the native and cleaved state, and in complex with active and inactive thrombin. These data show that the serpin undergoes conformational change upon forming a complex with either active or inactive proteinase. Steady-state fluorescence quenching measurements using potassium iodide were used to further probe the nature and extent of this conformational change. A pronounced conformational change is observed upon locking with an active proteinase; however, our data reveal that docking with the inactive proteinase thrombin(S195A) is also able to induce a conformational change in the serpin.
丝氨酸蛋白酶抑制剂 - 蛋白酶复合物的X射线晶体结构尚未确定。在本研究中,我们研究了抗胰蛋白酶在与无催化活性的(凝血酶(S195A))和活性凝血酶形成复合物过程中发生的构象变化。匹兹堡抗胰蛋白酶(一种有效的凝血酶抑制剂)的三个变体,每个变体都含有一个独特的半胱氨酸残基(Cys(232)、Cys(P3')和Cys(313)),用荧光探针N,N'-二甲基-N-(碘乙酰基)-N'-(7-硝基苯并-2-恶唑-1,3-二氮杂环丁烷-4-基)乙二胺进行共价修饰。荧光标记的存在不影响丝氨酸蛋白酶抑制剂的结构或抑制活性。我们监测了每种标记的丝氨酸蛋白酶抑制剂在天然和裂解状态下以及与活性和无活性凝血酶形成复合物时荧光发射光谱的变化。这些数据表明,丝氨酸蛋白酶抑制剂在与活性或无活性蛋白酶形成复合物时会发生构象变化。使用碘化钾进行的稳态荧光猝灭测量被用于进一步探究这种构象变化的性质和程度。与活性蛋白酶结合时观察到明显的构象变化;然而,我们的数据表明,与无活性蛋白酶凝血酶(S195A)对接也能够诱导丝氨酸蛋白酶抑制剂发生构象变化。